Medizinische Universität Graz - Research portal
Selected Publication:
Panzitt, M; Simon, M; Weger, M.
Persistence of bilateral pigmentary deposits in stromal cornea in a woman after a brief treatment with antidepressants
Klin Monatsbl Augenheilkd. 2001; 218(4):273-275
Doi: 10.1055/s-2001-14925
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
- Co-authors Med Uni Graz
- Weger Martin
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- BACKGROUND: Neuropsychiatric agents may affect the eye in various ways. Phenothiazine commonly used in the treatment of depressive psychosis and schizophrenia may induce pigmentary deposits in the eyelids, conjunctiva, cornea, lens and retina. PATIENT: We report on a case of a 60-year-old female patient who presented with pigmentary changes in the cornea of unknown origin. We found bilateral, axial brown dustlike deposits in the posterior stroma of the cornea. Further ophthalmic investigation revealed no other abnormalities. Seven years ago the patient underwent therapy with fluphenazine, a phenothiazine derivative. The corneal changes were similar to those described for chlorpromazine, which is also a phenothiazine derivative. CONCLUSION: Phenothiazine may induce pigmentary changes of the eye. Ophthalmic followup in patients with phenothiazine therapy seems to be necessary.
- Find related publications in this database (using NLM MeSH Indexing)
- Antipsychotic Agents - adverse effects
- Corneal Diseases - chemically induced
- Corneal Stroma - pathology
- Female - pathology
- Fluphenazine - adverse effects
- Humans - adverse effects
- Middle Aged - adverse effects
- Pigmentation Disorders - chemically induced
- Find related publications in this database (Keywords)
- phenothiazine
- fluphenazine
- cornea